Latest News about BLU
Recent news which mentions BLU
From Benzinga
From Benzinga
BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program
July 12, 2022
Tickers
BLU
From Benzinga
From Benzinga
Merck Coughs Up a Failure With Its "Pipeline in a Product"
February 03, 2022
From Motley Fool
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
‘Diamond-handed HODLers’ of GameStop and AMC take a Monday pummeling from the soft-handed crowd
December 13, 2021
From MarketWatch
Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
December 13, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
December 13, 2021
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
From Benzinga
From InvestorPlace
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
December 13, 2021
From InvestorPlace
From InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
December 13, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
October 14, 2021
Tags
NASDAQ:BLU,NASDAQ:ENTX,OTCMKTS:CYDY,OTCMKTS:ATRX,NASDAQ:DFFN,OTCMKTS:HALB,OTCMKTS:TSOI,NYSE:MRK
MRK
CYDY
From InvestorPlace
3 Biotech Stocks That Surged in September
October 05, 2021
From Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
46 Biggest Movers From Yesterday
September 15, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
September 14, 2021
From Benzinga
Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide
September 14, 2021
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August
September 14, 2021
From Benzinga